PMID- 30524196 OWN - NLM STAT- MEDLINE DCOM- 20190219 LR - 20190320 IS - 1466-1861 (Electronic) IS - 0962-9351 (Print) IS - 0962-9351 (Linking) VI - 2018 DP - 2018 TI - Amphiregulin Regulates Phagocytosis-Induced Cell Death in Monocytes via EGFR and Matrix Metalloproteinases. PG - 4310419 LID - 10.1155/2018/4310419 [doi] LID - 4310419 AB - Neonates are highly susceptible to microbial infections which is partially attributable to fundamental phenotypic and functional differences between effector cells of the adult and neonatal immune system. The resolution of the inflammation is essential to return to tissue homeostasis, but given that various neonatal diseases, such as periventricular leukomalacia, necrotizing enterocolitis, or bronchopulmonary dysplasia, are characterized by sustained inflammation, newborns seem predisposed to a dysregulation of the inflammatory response. Targeted apoptosis of effector cells is generally known to control the length and extent of the inflammation, and previous studies have demonstrated that phagocytosis-induced cell death (PICD), a special type of apoptosis in phagocytic immune cells, is less frequently triggered in neonatal monocytes than in adult monocytes. We concluded that a rescue of monocyte PICD could be a potential therapeutic approach to target sustained inflammation in neonates. The EGFR ligand amphiregulin (AREG) is shed in response to bacterial infection and was shown to mediate cellular apoptosis resistance. We hypothesized that AREG might contribute to the reduced PICD of neonatal monocytes by affecting apoptosis signaling. In this study, we have examined a cascade of signaling events involved in extrinsic apoptosis by using a well-established in vitro E. coli infection model in monocytes from human peripheral blood (PBMO) and cord blood (CBMO). We found that CBMO shows remarkably higher pro-AREG surface expression as well as soluble AREG levels in response to infection as compared to PBMO. AREG increases intracellular MMP-2 and MMP-9 levels and induces cleavage of membrane-bound FasL through engagement with the EGF receptor. Our results demonstrate that loss of AREG rescues PICD in CBMO to the level comparable to adult monocytes. These findings identify AREG as a potential target for the prevention of prolonged inflammation in neonates. FAU - Platen, Christopher AU - Platen C AUID- ORCID: 0000-0003-4063-7789 AD - Department of Neonatology, University Children's Hospital, Aachen, Germany. FAU - Dreschers, Stephan AU - Dreschers S AUID- ORCID: 0000-0003-2527-3673 AD - Department of Neonatology, University Children's Hospital, Aachen, Germany. FAU - Reiss, Lucy Kathleen AU - Reiss LK AUID- ORCID: 0000-0001-9567-3328 AD - Institute of Pharmacology and Toxicology, Medical Faculty, RWTH Aachen University, Aachen, Germany. FAU - Wappler, Jessica AU - Wappler J AUID- ORCID: 0000-0003-1431-9613 AD - Molecular Tumor Biology, Department of General, Visceral and Transplantation Surgery, University Hospital, Aachen, Germany. FAU - Orlikowsky, Thorsten W AU - Orlikowsky TW AUID- ORCID: 0000-0001-7123-0629 AD - Department of Neonatology, University Children's Hospital, Aachen, Germany. LA - eng PT - Journal Article DEP - 20181104 PL - United States TA - Mediators Inflamm JT - Mediators of inflammation JID - 9209001 RN - 0 (Amphiregulin) RN - EC 2.7.10.1 (EGFR protein, human) RN - EC 2.7.10.1 (ErbB Receptors) RN - EC 3.4.24.- (Matrix Metalloproteinases) RN - EC 3.4.24.24 (Matrix Metalloproteinase 2) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) SB - IM MH - Amphiregulin/genetics/*metabolism MH - Apoptosis/genetics/physiology MH - Cell Death/genetics/*physiology MH - Cells, Cultured MH - Enzyme-Linked Immunosorbent Assay MH - ErbB Receptors/genetics/metabolism MH - Escherichia coli/pathogenicity MH - Flow Cytometry MH - Humans MH - Matrix Metalloproteinase 2/genetics/metabolism MH - Matrix Metalloproteinase 9/genetics/metabolism MH - Matrix Metalloproteinases/genetics/metabolism MH - Monocytes/*cytology/*metabolism MH - Phagocytosis/genetics/*physiology PMC - PMC6247478 EDAT- 2018/12/14 06:00 MHDA- 2019/03/21 06:00 PMCR- 2018/11/04 CRDT- 2018/12/08 06:00 PHST- 2018/04/24 00:00 [received] PHST- 2018/07/26 00:00 [revised] PHST- 2018/08/29 00:00 [accepted] PHST- 2018/12/08 06:00 [entrez] PHST- 2018/12/14 06:00 [pubmed] PHST- 2019/03/21 06:00 [medline] PHST- 2018/11/04 00:00 [pmc-release] AID - 10.1155/2018/4310419 [doi] PST - epublish SO - Mediators Inflamm. 2018 Nov 4;2018:4310419. doi: 10.1155/2018/4310419. eCollection 2018.